Abstract
We describe a patient with marked elevations of creatine kinase following institution of clozapine treatment. The enzyme levels promptly subsided with discontinuation of clozapine. The clinical features did not meet any of the published criteria for neuroleptic malignant syndrome.
MeSH terms
-
Adult
-
Clozapine / adverse effects*
-
Clozapine / therapeutic use
-
Creatine Kinase / blood*
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Humans
-
Male
-
Neuroleptic Malignant Syndrome / diagnosis
-
Neuroleptic Malignant Syndrome / enzymology
-
Schizophrenia, Paranoid / diagnosis
-
Schizophrenia, Paranoid / drug therapy*
-
Schizophrenia, Paranoid / enzymology
-
Schizophrenia, Paranoid / psychology
Substances
-
Creatine Kinase
-
Clozapine